| Mean ± SD | 95% CI | ANOVA p value |
---|---|---|---|
Infarct MD | 0.070 | ||
 LAD territory | 1.79 ± 1.22 | 1.71–1.84 |  |
 LCX territory | 1.55 ± 0.14 | 0.28–2.82 |  |
 RCA territory | 1.73 ± 0.14 | 1.64–1.81 |  |
Infarct FA | 0.552 | ||
 LAD territory | 0.24 ± 0.32 | 0.22–0.26 |  |
 LCX territory | 0.27 ± 0.07 | 0.20–0.33 |  |
 RCA territory | 0.24 ± 0.03 | 0.22–0.27 |  |
Infarct E2A | 0.152 | ||
 LAD territory | 40.14 ± 9.53 | 35.24–45.04 |  |
 LCX territory | 48.60 ± 0.35 | 45.42–51.78 |  |
 RCA territory | 45.13 ± 5.77 | 41.64–48.62 |  |
Infarct Endo | 0.741 | ||
 LAD territory | 0.12 ± 0.05 | 0.09–0.14 |  |
 LCX territory | 0.15 ± 0.04 | − 0.17–0.46 |  |
 RCA territory | 0.12 ± 0.04 | 0.10–0.14 |  |
Infarct mid | 0.591 | ||
 LAD territory | 0.70 ± 0.09 | 0.65–0.74 |  |
 LCX territory | 0.77 ± 0.04 | 0.45–1.08 |  |
 RCA territory | 0.72 ± 0.10 | 0.66–0.78 |  |
Infarct epi | 0.310 | ||
 LAD territory | 0.19 ± 0.10 | 0.14–0.25 |  |
 LCX territory | 0.09 ± 0.00 | 0.09–0.09 |  |
 RCA territory | 0.16 ± 0.11 | 0.09–0.22 |  |